7800   Burn scar(s) of the head, face, or neck; scar(s) of the head, face, or neck due to other causes; or other disfigurement of the head, face, or neck: With visible or palpable tissue loss and either gross distortion or asymmetry of three or more features or paired sets of features (nose, chin, forehead, eyes (including eyelids), ears (auricles), cheeks, lips), or; with six or more characteristics of disfigurement 80
7800   Burn scar(s) of the head, face, or neck; scar(s) of the head, face, or neck due to other causes; or other disfigurement of the head, face, or neck: With visible or palpable tissue loss and either gross distortion or asymmetry of two features or paired sets of features (nose, chin, forehead, eyes (including eyelids), ears (auricles), cheeks, lips), or; with four or five characteristics of disfigurement 50
7800   Burn scar(s) of the head, face, or neck; scar(s) of the head, face, or neck due to other causes; or other disfigurement of the head, face, or neck: With visible or palpable tissue loss and either gross distortion or asymmetry of one feature or paired set of features (nose, chin, forehead, eyes (including eyelids), ears (auricles), cheeks, lips), or; with two or three characteristics of disfigurement 30
7800   Burn scar(s) of the head, face, or neck; scar(s) of the head, face, or neck due to other causes; or other disfigurement of the head, face, or neck: With one characteristic of disfigurement 10
7801   Burn scar(s) or scar(s) due to other causes, not of the head, face, or neck, that are associated with underlying soft tissue damage: Area or areas of 144 square inches (929 sq. cm.) or greater 40
7801   Burn scar(s) or scar(s) due to other causes, not of the head, face, or neck, that are associated with underlying soft tissue damage: Area or areas of at least 72 square inches (465 sq. cm.) but less than 144 square inches (929 sq. cm.) 30
7801   Burn scar(s) or scar(s) due to other causes, not of the head, face, or neck, that are associated with underlying soft tissue damage: Area or areas of at least 12 square inches (77 sq. cm.) but less than 72 square inches (465 sq. cm.) 20
7801   Burn scar(s) or scar(s) due to other causes, not of the head, face, or neck, that are associated with underlying soft tissue damage: Area or areas of at least 6 square inches (39 sq. cm.) but less than 12 square inches (77 sq. cm.) 10
7802 Burn scar(s) or scar(s) due to other causes, not of the head, face, or neck, that are not associated with underlying soft tissue damage: Area or areas of 144 square inches (929 sq. cm.) or greater 10
7804   Scar(s), unstable or painful: Five or more scars that are unstable or painful 30
7804   Scar(s), unstable or painful: Three or four scars that are unstable or painful 20
7804   Scar(s), unstable or painful: One or two scars that are unstable or painful 10
7805   Scars, other; and other effects of scars evaluated under diagnostic codes 7800, 7801, 7802, or 7804: Evaluate any disabling effect(s) not considered in a rating provided under diagnostic codes 7800-04 under an appropriate diagnostic code General Rating Formula For The Skin For DCs 7806, 7809, 7813-7816, 7820-7822, and 7824: At least one of the following 60
7805   Scars, other; and other effects of scars evaluated under diagnostic codes 7800, 7801, 7802, or 7804: Characteristic lesions involving more than 40 percent of the entire body or more than 40 percent of exposed areas affected; or Constant or near-constant systemic therapy including, but not limited to, corticosteroids, phototherapy, retinoids, biologics, photochemotherapy, psoralen with long-wave ultraviolet-A light (PUVA), or other immunosuppressive drugs required over the past 12-month period 60
7805   Scars, other; and other effects of scars evaluated under diagnostic codes 7800, 7801, 7802, or 7804: At least one of the following 30
7805   Scars, other; and other effects of scars evaluated under diagnostic codes 7800, 7801, 7802, or 7804: Characteristic lesions involving 20 to 40 percent of the entire body or 20 to 40 percent of exposed areas affected; or Systemic therapy including, but not limited to, corticosteroids, phototherapy, retinoids, biologics, photochemotherapy, PUVA, or other immunosuppressive drugs required for a total duration of 6 weeks or more, but not constantly, over the past 12-month period At least one of the following 10
7805   Scars, other; and other effects of scars evaluated under diagnostic codes 7800, 7801, 7802, or 7804: Characteristic lesions involving at least 5 percent, but less than 20 percent, of the entire body affected; or At least 5 percent, but less than 20 percent, of exposed areas affected; or Intermittent systemic therapy including, but not limited to, corticosteroids, phototherapy, retinoids, biologics, photochemotherapy, PUVA, or other immunosuppressive drugs required for a total duration of less than 6 weeks over the past 12-month period No more than topical therapy required over the past 12-month period and at least one of the following 0
7805   Scars, other; and other effects of scars evaluated under diagnostic codes 7800, 7801, 7802, or 7804: Characteristic lesions involving less than 5 percent of the entire body affected; or Characteristic lesions involving less than 5 percent of exposed areas affected Or rate as disfigurement of the head, face, or neck (DC 7800) or scars (DCs 7801, 7802, 7804, or 7805), depending upon the predominant disability. This rating instruction does not apply to DC 7824
7809   Discoid lupus erythematosus. Evaluate under the General Rating Formula for the Skin Note: Do not combine with ratings under DC 6350
7817   Erythroderma: Generalized involvement of the skin with systemic manifestations (such as fever, weight loss, or hypoproteinemia) AND one of the following 100
7817   Erythroderma: Constant or near-constant systemic therapy such as therapeutic doses of corticosteroids, other immunosuppressive drugs, retinoids, PUVA (psoralen with long-wave ultraviolet-A light), UVB (ultraviolet-B light) treatments, biologics, or electron beam therapy required over the past 12 month period; or No current treatment due to a documented history of treatment failure with 2 or more treatment regimens 100
7817   Erythroderma: Generalized involvement of the skin without systemic manifestations and one of the following Constant or near-constant systemic therapy such as therapeutic doses of corticosteroids, other immunosuppressive drugs, retinoids, PUVA, UVB treatments, biologics, or electron beam therapy required over the past 12-month period; or No current treatment due to a documented history of treatment failure with 1 treatment regimen 60
7817   Erythroderma: Any extent of involvement of the skin, and any of the following therapies required for a total duration of 6 weeks or more, but not constantly, over the past 12-month period: systemic therapy such as therapeutic doses of corticosteroids, other immunosuppressive drugs, retinoids, PUVA, UVB treatments, biologics, or electron beam therapy 30
7817   Erythroderma: Any extent of involvement of the skin, and any of the following therapies required for a total duration of less than 6 weeks over the past 12-month period: systemic therapy such as therapeutic doses of corticosteroids, other immunosuppressive drugs, retinoids, PUVA, UVB treatments, biologics, or electron beam therapy 10
7817   Erythroderma: Any extent of involvement of the skin, and no more than topical therapy required over the past 12-month period 0
7823   Vitiligo: With exposed areas affected 10
7823   Vitiligo: With no exposed areas affected 0
7825   Chronic urticaria: For the purposes of this diagnostic code, chronic urticaria is defined as continuous urticaria at least twice per week, off treatment, for a period of six weeks or more Chronic refractory urticaria that requires third line treatment for control (e.g., plasmapheresis, immunotherapy, immunosuppressives) due to ineffectiveness with first and second line treatments 60
7825   Chronic urticaria: Chronic urticaria that requires second line treatment (e.g., corticosteroids, sympathomimetics, leukotriene inhibitors, neutrophil inhibitors, thyroid hormone) for control 30
7825   Chronic urticaria: Chronic urticaria that requires first line treatment (antihistamines) for control 10
7826   Vasculitis, primary cutaneous: Persistent documented vasculitis episodes refractory to continuous immunosuppressive therapy 60
7826   Vasculitis, primary cutaneous: All of the following 30
7826   Vasculitis, primary cutaneous: Recurrent documented vasculitic episodes occurring four or more times over the past 12-month period; and Requiring intermittent systemic immunosuppressive therapy for control 30
7826   Vasculitis, primary cutaneous: At least one of the following 10
7827   Erythema multiforme; Toxic epidermal necrolysis: Recurrent mucosal, palmar, or plantar involvement impairing mastication, use of hands, or ambulation occurring four or more times over the past 12-month period despite ongoing immunosuppressive therapy 60
7827   Erythema multiforme; Toxic epidermal necrolysis: All of the following 30
7827   Erythema multiforme; Toxic epidermal necrolysis: Recurrent mucosal, palmar, or plantar involvement not impairing mastication, use of hands, or ambulation, occurring four or more times over the past 12-month period; andrequiring intermittent systemic therapy At least one of the following 10
7828   Acne: Deep acne (deep inflamed nodules and pus-filled cysts) affecting 40 percent or more of the face and neck 30
7828   Acne: Deep acne (deep inflamed nodules and pus-filled cysts) affecting less than 40 percent of the face and neck, or deep acne other than on the face and neck 10
7828   Acne: Superficial acne (comedones, papules, pustules) of any extent 0
7829   Chloracne: Deep acne (deep inflamed nodules and pus-filled cysts) affecting 40 percent or more of the face and neck 30
7829   Chloracne: Deep acne (deep inflamed nodules and pus-filled cysts) affecting the intertriginous areas (the axilla of the arm, the anogenital region, skin folds of the breasts, or between digits) 20
7829   Chloracne: Deep acne (deep inflamed nodules and pus-filled cysts) affecting less than 40 percent of the face and neck; or deep acne affecting non-intertriginous areas of the body (other than the face and neck) 10
7829   Chloracne: Superficial acne (comedones, papules, pustules) of any extent 0
7830   Scarring alopecia: Affecting more than 40 percent of the scalp 20
7830   Scarring alopecia: Affecting 20 to 40 percent of the scalp 10
7830   Scarring alopecia: Affecting less than 20 percent of the scalp 0
7831   Alopecia areata: With loss of all body hair 10
7831   Alopecia areata: With loss of hair limited to scalp and face 0
7832   Hyperhidrosis: Unable to handle paper or tools because of moisture, and unresponsive to therapy 30
7832   Hyperhidrosis: Able to handle paper or tools after therapy 0
